Artificial intelligence (AI) in medicine has shown both promise and pitfalls. While there’s enthusiasm for its potential in drug discovery and diagnosing conditions, there have been instances of inaccurate predictions and unintended consequences. The Food and Drug Administration (FDA) is actively discussing AI’s role but faces criticism over its vetting process. President Biden has issued an executive order addressing AI’s security and privacy risks in health care. Doctors seek clarity on how AI tools are developed and tested. Concerns also arise from the lack of transparency and publicly available information on these tools. As AI’s presence in health care grows, there’s a pressing need for rigorous testing and a robust regulatory framework.